130 related articles for article (PubMed ID: 28092388)
1. Exploration and analysis of drug modes of action through feature integration.
Xin M; Fan J; Liu M; Jiang Z
Mol Biosyst; 2017 Jan; 13(2):425-431. PubMed ID: 28092388
[TBL] [Abstract][Full Text] [Related]
2. Prediction of polypharmacological profiles of drugs by the integration of chemical, side effect, and therapeutic space.
Cheng F; Li W; Wu Z; Wang X; Zhang C; Li J; Liu G; Tang Y
J Chem Inf Model; 2013 Apr; 53(4):753-62. PubMed ID: 23527559
[TBL] [Abstract][Full Text] [Related]
3. A Bayesian network model for predicting aquatic toxicity mode of action using two dimensional theoretical molecular descriptors.
Carriger JF; Martin TM; Barron MG
Aquat Toxicol; 2016 Nov; 180():11-24. PubMed ID: 27640153
[TBL] [Abstract][Full Text] [Related]
4. SDTNBI: an integrated network and chemoinformatics tool for systematic prediction of drug-target interactions and drug repositioning.
Wu Z; Cheng F; Li J; Li W; Liu G; Tang Y
Brief Bioinform; 2017 Mar; 18(2):333-347. PubMed ID: 26944082
[TBL] [Abstract][Full Text] [Related]
5. iDrug: Integration of drug repositioning and drug-target prediction via cross-network embedding.
Chen H; Cheng F; Li J
PLoS Comput Biol; 2020 Jul; 16(7):e1008040. PubMed ID: 32667925
[TBL] [Abstract][Full Text] [Related]
6. DrugNet: network-based drug-disease prioritization by integrating heterogeneous data.
Martínez V; Navarro C; Cano C; Fajardo W; Blanco A
Artif Intell Med; 2015 Jan; 63(1):41-9. PubMed ID: 25704113
[TBL] [Abstract][Full Text] [Related]
7. Network-based inference methods for drug repositioning.
Chen H; Zhang H; Zhang Z; Cao Y; Tang W
Comput Math Methods Med; 2015; 2015():130620. PubMed ID: 25969690
[TBL] [Abstract][Full Text] [Related]
8. Adverse drug events: database construction and in silico prediction.
Cheng F; Li W; Wang X; Zhou Y; Wu Z; Shen J; Tang Y
J Chem Inf Model; 2013 Apr; 53(4):744-52. PubMed ID: 23521697
[TBL] [Abstract][Full Text] [Related]
9. Discovery of multitarget-directed ligands against Alzheimer's disease through systematic prediction of chemical-protein interactions.
Fang J; Li Y; Liu R; Pang X; Li C; Yang R; He Y; Lian W; Liu AL; Du GH
J Chem Inf Model; 2015 Jan; 55(1):149-64. PubMed ID: 25531792
[TBL] [Abstract][Full Text] [Related]
10. A Bayesian Target Predictor Method based on Molecular Pairing Energies estimation.
Oliver A; Canals V; Rosselló JL
Sci Rep; 2017 Mar; 7():43738. PubMed ID: 28263323
[TBL] [Abstract][Full Text] [Related]
11. In silico prediction of chemical mechanism of action via an improved network-based inference method.
Wu Z; Lu W; Wu D; Luo A; Bian H; Li J; Li W; Liu G; Huang J; Cheng F; Tang Y
Br J Pharmacol; 2016 Dec; 173(23):3372-3385. PubMed ID: 27646592
[TBL] [Abstract][Full Text] [Related]
12. Machine learning-based prediction of drug-drug interactions by integrating drug phenotypic, therapeutic, chemical, and genomic properties.
Cheng F; Zhao Z
J Am Med Inform Assoc; 2014 Oct; 21(e2):e278-86. PubMed ID: 24644270
[TBL] [Abstract][Full Text] [Related]
13. Computational drug repositioning with attention walking.
Park JH; Cho YR
Sci Rep; 2024 May; 14(1):10072. PubMed ID: 38698208
[TBL] [Abstract][Full Text] [Related]
14. Drug target prediction and repositioning using an integrated network-based approach.
Emig D; Ivliev A; Pustovalova O; Lancashire L; Bureeva S; Nikolsky Y; Bessarabova M
PLoS One; 2013; 8(4):e60618. PubMed ID: 23593264
[TBL] [Abstract][Full Text] [Related]
15. In silico drug repositioning: from large-scale transcriptome data to therapeutics.
Kwon OS; Kim W; Cha HJ; Lee H
Arch Pharm Res; 2019 Oct; 42(10):879-889. PubMed ID: 31482491
[TBL] [Abstract][Full Text] [Related]
16. Prediction of chemical-protein interactions network with weighted network-based inference method.
Cheng F; Zhou Y; Li W; Liu G; Tang Y
PLoS One; 2012; 7(7):e41064. PubMed ID: 22815915
[TBL] [Abstract][Full Text] [Related]
17. Prioritization of candidate cancer drugs based on a drug functional similarity network constructed by integrating pathway activities and drug activities.
Di J; Zheng B; Kong Q; Jiang Y; Liu S; Yang Y; Han X; Sheng Y; Zhang Y; Cheng L; Han J
Mol Oncol; 2019 Oct; 13(10):2259-2277. PubMed ID: 31408580
[TBL] [Abstract][Full Text] [Related]
18. Computational-experimental approach to drug-target interaction mapping: A case study on kinase inhibitors.
Cichonska A; Ravikumar B; Parri E; Timonen S; Pahikkala T; Airola A; Wennerberg K; Rousu J; Aittokallio T
PLoS Comput Biol; 2017 Aug; 13(8):e1005678. PubMed ID: 28787438
[TBL] [Abstract][Full Text] [Related]
19. Target-Based Drug Repositioning Using Large-Scale Chemical-Protein Interactome Data.
Sawada R; Iwata H; Mizutani S; Yamanishi Y
J Chem Inf Model; 2015 Dec; 55(12):2717-30. PubMed ID: 26580494
[TBL] [Abstract][Full Text] [Related]
20. Drug repositioning for enzyme modulator based on human metabolite-likeness.
Lee YH; Choi H; Park S; Lee B; Yi GS
BMC Bioinformatics; 2017 May; 18(Suppl 7):226. PubMed ID: 28617219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
